The US Food and Drug
Administration has introduced
regulatory control around the
safety and effectiveness of
antibacterial soaps in general use.
Although consumers generally
view these products as effective
tools to help prevent the spread
of germs, there is currently no
evidence that they are any more
effective at preventing illness than
washing with plain soap and water,
the agency said.
Manufacturers will be required
to submit their products to testing
the results of which will determine
their right to market.
The proposed rule doesn’t
affect hand sanitisers, wipes or
antibacterial products used in
health care settings.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Dec 13
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.